University of Colorado-Boulder
|
|
- Jade Gwendoline Marsh
- 5 years ago
- Views:
Transcription
1 University of Colorado-Boulder Activated Glia as Culprits in Opposing Opioid Analgesia & Driving Tolerance, Dependence & Reward: Role of a Non-classical Non-classical Opioid Receptor Linda R. Watkins Psychology & Center for Neuroscience University of Colorado at Boulder 1
2 CU-Boulder: Kim Brown Ben Coats Susannah Lewis Steven Maier Alexis Northcutt Niloofar Rezvani University of Adelaide Mark Hutchinson University of Sydney Ian Johnston National Institute Drug Abuse/NIH Kenner Rice Global Concepts Views of pain & opioid effects are changing Glia (microglia (microglia & astrocytes) in CNS are key players in: * pain amplification, including pathological pain * making acute opioids (such as morphine) less effective for pain control * causing chronic morphine to lose effect, contributing to opioid tolerance * driving morphine dependence/withdrawal * driving morphine reward, linked to drug craving * driving other opioid-induced negative side effects Opioids activate glia via a non-classical opioid receptor 2
3 Global Concepts Views of pain & opioid effects are changing Glia (microglia( & astrocytes) in CNS are key players in: * pain amplification, including pathological pain * making acute opioids (such as morphine) less effective for pain control * causing chronic morphine to lose effect, contributing to opioid tolerance * driving morphine dependence/withdrawal * driving morphine reward, linked to drug craving * driving other opioid-induced negative side effects Opioids activate glia via a non-classical opioid receptor Global Concepts Views of pain & opioid effects are changing Glia (microglia( & astrocytes) in CNS are key players in: * pain amplification, including pathological pain * making acute opioids (such as morphine) less effective for pain control * causing chronic morphine to lose effect, contributing to opioid tolerance * driving morphine dependence/withdrawal * driving morphine reward, linked to drug craving * driving other opioid-induced negative side effects Opioids activate glia via a non-classical opioid receptor 3
4 Global Concepts Views of pain & opioid effects are changing Glia (microglia( & astrocytes) in CNS are key players in: * pain amplification, including pathological pain * making acute opioids (such as morphine) less effective for pain control * causing chronic morphine to lose effect, contributing to opioid tolerance * driving morphine dependence/withdrawal * driving morphine reward, linked to drug craving * driving other opioid-induced negative side effects Opioids activate glia via a non-classical opioid receptor Global Concepts Views of pain & opioid effects are changing Glia (microglia( & astrocytes) in CNS are key players in: * pain amplification, including pathological pain * making acute opioids (such as morphine) less effective for pain control * causing chronic morphine to lose effect, contributing to opioid tolerance * driving morphine dependence/withdrawal * driving morphine reward, linked to drug craving * driving other opioid-induced negative side effects Opioids activate glia via a non-classical opioid receptor 4
5 Global Concepts Views of pain & opioid effects are changing Glia (microglia( & astrocytes) in CNS are key players in: * pain amplification, including pathological pain * making acute opioids (such as morphine) less effective for pain control * causing chronic morphine to lose effect, contributing to opioid tolerance * driving morphine dependence/withdrawal * driving morphine reward, linked to drug craving * driving other opioid-induced negative side effects Opioids activate glia via a non-classical opioid receptor Global Concepts Views of pain & opioid effects are changing Glia (microglia( & astrocytes) in CNS are key players in: * pain amplification, including pathological pain * making acute opioids (such as morphine) less effective for pain control * causing chronic morphine to lose effect, contributing to opioid tolerance * driving morphine dependence/withdrawal * driving morphine reward, linked to drug craving * driving other opioid-induced negative side effects Opioids activate glia via a non-classical opioid receptor 5
6 Neuropathic Pain Glial Dysregulation of Pain Activation of: *Microglia *Astrocytes Release of: *Interleukin-1 *Interleukin-6 *Tumor Necrosis factor Each Enhance Pain Effects Synergize Watkins et al., Brain Research Reviews
7 Glial Dysregulation of Opioids Activation of: *Microglia *Astrocytes Release of: *Interleukin-1 *Interleukin-6 *Tumor Necrosis factor Each Enhance Pain Results in: * Analgesia * Naïve tolerance * Tolerance * Dependence * Reward * Side Effects Effects Synergize Hutchinson et al., TheScientificWorldJournal 2007 The initial discovery of glial regulation of opioid actions was made in the context of Morphine Tolerance 7
8 Glial Activation by Repeated Morphine GFAP: Spinal Cord Saline Morphine Close Up Of Glia Song & Zhao, Neurosci. Research 2001 Chronic i.t. Morphine Increases Spinal Cord Interleukin-1 Johnston et al., Journal of Neuroscience 04 8
9 Spinal : i.t. Morphine Tolerance & Withdrawal-Induced Pain Facilitation (Johnston et al. Journal of Neuroscience 04) Tailflick Latency (sec) Based on these hints, we began exploring glial regulation of Acute Morphine Analgesia 9
10 Glial Activation Opposes the Analgesic Efficacy of Both Acute i.t. Morphine & i.t. Methadone Percent of Maximal Possible Effect BL Timecourse (Minutes) BL Timecourse (Minutes) Hutchinson et al., MS in review Spinal Glial Activation Opposes the Analgesic Efficacy of Systemic Morphine, Too! Hutchinson et al., MS in review 10
11 Intrathecal ra Unmasks Morphine Analgesia Analgesia Morphine Behavioral output =Morphine + Pain Interleukin-1 Intrathecal ra Unmasks Morphine Analgesia Analgesia Morphine Pain ra Interleukin-1 11
12 Spinal Glial Opposition of Morphine: involvement of multiple proinflammatory cytokines Hutchinson et al., MS in review Spinal Glial Opposition of Morphine: Microglia implicated - Hutchinson et al., MS in review Hutchinson et al., Society for Neuroscience,
13 i.t. ra Enhances Morphine: Leftward Dose-Response Shift Hutchinson et al., MS in review i.t. ra Amplifies i.t. Morphine: Leftward Dose-Response Shift Hutchinson et al., MS in review 13
14 i.t. ra: Enhanced Efficacy of Morphine: NOT Due to Altered Pharmacokinetics Circles: Morphine in CSF (ng/ul) With IL1ra; Without IL1ra Squares: Morphine in Spinal Cord (ng/mg) With IL1ra; Without IL1ra Hutchinson et al., MS in review 2007 Does Glial Dysregulation of Opioids Only Occur in Spinal Cord? Might suppressing glial activation impact brain mediated: * Dependence/withdrawal? * Reward? * Other negative side effects? 14
15 AV411 Blocks Naloxone-Precipitated Morphine Withdrawal (Hutchinson et al., MS in review 2008) Behavioral Withdrawal Score Naltrexone to Precipitate Withdrawal Vehicle + Morphine Timecourse (Minutes) AV411 Blunts Morphine-Induced Release of Nucleus Accumbens Dopamine, by In Vivo Microdialysis 5 days of twice daily: Morphine + Vehicle Bland et al. MS in prep 08 Morphine + AV411 Reward Vehicle or AV411 + Saline Dopamine Timecourse (20 min collection intervals) 15
16 AV411 Blunts Morphine-Induced Release of Nucleus Accumbens Dopamine, by In Vivo Microdialysis 5 days of twice daily: Morphine + Vehicle Bland et al. MS in prep 08 Morphine + AV411 Reward Vehicle or AV411 + Saline Dopamine Timecourse (20 min collection intervals) Glia & Opioid Reward: Conditioned Place Preference Morphine/Saline Test Pre-exposure place preference Saline Morphine Saline paired Saline paired 16
17 Inhibiting Glial Activation Suppresses Morphine Reward as Measured by CPP Reward Hutchinson et al., MS in review 08 Glial Inhibitor Suppresses Respiratory Depression Morphine + Vehicle Mor + 25 mg/kg Minocycline Mor + 50 mg/kg Minocycline Minute Volume v Veh + 50 mg/kg Mino Vehicle + Vehicle Inspiratory Force Hutchinson et al. MS in review 08 17
18 Opioid Effects are Different for Neurons & Glia Neuronal Receptors are Stereoselective: [-]Methadone: [+]Methadone: Active Agonist INActive Agonist at Classical Opioid Receptor at Classical Opioid Receptor Opioid Effects are Different for Neurons & Glia Neuronal Receptors are Stereoselective: [-]-Naloxone: [+]-Naloxone: Active Antagonist INactive Antagonist at Classical Opioid Receptor at Classical Opioid Receptor This Point is KEY 18
19 Classical view of opioid-induced analgesia Neuron (+)-Opioid ANALGESIA Opioid Effects are Different for Neurons & Glia GLIAL Receptors are Not Stereoselective! [-]& [+] Isomers have EQUAL effects on glia [-]-Methadone: Active Agonist at Glial Opioid Receptor [+]-Methadone: Active Agonist at Glial Opioid Receptor Glial opioid receptor -- Fits BOTH [-] & [+]-enantiomers 19
20 What if Glial Non-Stereoselectivity Extends to Opioid Antagonists? [-]-Naloxone: Active Antagonist at Glial Opioid receptor [+]-Naloxone: Active Antagonist at Glial Opioid receptor [+]-Naloxone should POTENTIATE morphine analgesia by: (a) NOT blocking morphine effects on neurons, yet (b) Removing glial activation that OPPOSES analgesia! Neuronally INACTIVE [+]-Naloxone Potentiates Morphine Analgesia! Suggests Effects on Glia & Neurons May be Separable! Hutchinson et al., MS in prep 08 20
21 Neuronally INACTIVE (+)-Naltrexone Potentiates Morphine Analgesia, Too! 100 Morphine alone Morphine + (+)-Naltrexone ** *** *** *** *** * ** * IL1ra 0 BL Time (min post IT drug admin) Hutchinson et al., MS in prep 08 Opioid Activation of Glia Suppresses Analgesia ANALGESIA Analgesia TLR4 21
22 Opioid Activation of Glia Suppresses Analgesia: Blockade by (+)-Naloxone (+)-naloxone TLR4 ANALGESIA Why is This Important? This Difference Predicts: Morphine effects on neurons & glia should be separable! ) 22
23 Why is This Important? This Difference Predicts: Morphine effects on neurons & glia ) should be separable! To increase the efficacy of opioids: * structurally modify opioids to prevent glial activation, or * create a long-lasting version of (+)-naloxone that only blocks glia Soooooo. What s s the mystery opioid receptor on glia? To target it, one must know what it is Toll-Like Receptors (TLRs): Classically. not me, not right, not OK receptors Toll-Like Receptors (TLRs) detect: *pathogens (bacteria, viruses, etc.) *endogenous danger signals (damage/death) * All classes of opioids used clinically Hutchinson et al., TheScientificWorldJournal
24 This isn t t just morphine! All major classes of clinically utilized opioid analgesics are TLR4 agonists 4,5-epoxymorphinans: morphine, oxycodone, buprenorphine 3,3-diphenylpropylamine: methadone 4-phenylpiperidine: pethadine 4-amilinopiperidine: fentanyl Hutchinson et al., MS in prep 08 TLR4 Induced Glial Activation TLR4 expression is upregulated by: * Neuropathy * Opioids, non-stereoselectively TLR4 is activated by: * Neuropathy * Opioid agonists, non-stereoselectively TLR4 is blocked by: * Naloxone, non-stereoselectively Hutchinson et al., TheScientificWorldJournal
25 Toll Like Receptor-4 (TLR4): (+)-Naloxone, a TLR4 antagonist, non-stereoselectively reverses neuropathic pain Hutchinson et al., in review (+)-Naloxone Reverses CCI Neuropathy-Induced Microglial Activation Each Panel: Spinal cord dorsal horn ipsilateral to nerve injury Saline (+)-Naloxone 25
26 Neuropathy-Induced Glial Activation & Pain: TLR4 is Key Glial activation in spinal dorsal horn & neuropathic pain are suppressed in TLR4 KOs TLR4 Knock Outs Wild Type Tanga et al. PNAS 05 TLR induced glial activation: Opioids Glia TLR4 Neuronal Consequences Neuron 26
27 TLR induced glial activation: Endogenous danger signals Glia Neuron Neuronal Consequences Neuron TLR induced glial activation: Endog. danger signals + Opioids Neuron Glia Naïve Tolerance Neuronal Consequences Neuron 27
28 Conclusions - 1 So, Taken Together The Data Predict That Suppressing Glial Activation Will: Suppress neuropathic pain, etc. Improve opioid analgesia Suppress opioid tolerance Suppress opioid dependence Suppress opioid reward linked to drug craving/drug seeking Suppress other negative side effects 28
29 Conclusions - 2 Opioid Activation of Glia is Fundamentally Different Than Neurons: Glial opioid receptors: not stereoselective Opioid effects on glia must be via different receptors than for neurons: TLR4 Effects on glia & neurons should be separable To increase the efficacy of opioids: * Modify opioids so they don t bind glia &/or * Create long-lasting versions of [+]-naloxone Conclusions - 3 TLR4: Pivotal for Glial Activation by BOTH Opioids & Neuropathic Pain TLR4: Activated by both opioids & neuropathic pain Activation of TLR4 by nerve injury: endogenous danger signals released by stressed/injured cells (+)-Naloxone as a stand alone drug, treats neuropathic pain as a TLR4 antagonist 29
30 Colorado - High on Science! AV411 Suppresses Chronic Morphine Induced Glial Activation (Hutchinson et al. MS in review) Morphine+Vehicle Morphine + AV411 PAG Trigem. Nuclei 30
The Toll of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia
Review The Toll of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia Linda R. Watkins 1, Mark R. Hutchinson 1,2, Kenner C. Rice 3 and Steven F. Maier 1 1 Department
More informationOpioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia, Dependence, and Reward
Mini-Review NIDA Special Issue on Frontiers in Addiction Research ISSN 1537-744X; DOI 10.1100/tsw.2007.230 Opioid-Induced Glial Activation: Mechanisms of Activation and Implications for Opioid Analgesia,
More informationTHE OPIUM POPPY OPIOID PHARMACOLOGY 2/18/16. PCTH 300/305 Andrew Horne, PhD MEDC 309. Papaver somniferum. Poppy Seeds Opiates
OPIOID PHARMACOLOGY PCTH 300/305 Andrew Horne, PhD andrew.horne@ubc.ca MEDC 309 THE OPIUM POPPY Papaver somniferum Sleep-bringing poppy Poppy Seeds Opiates Opium Poppy Straw 1 OPIATES VS. OPIOIDS Opiates:
More informationPAIN & ANALGESIA. often accompanied by clinical depression. fibromyalgia, chronic fatigue, etc. COX 1, COX 2, and COX 3 (a variant of COX 1)
Pain - subjective experience associated with detection of tissue damage ( nociception ) acute - serves as a warning chronic - nociception gone bad often accompanied by clinical depression fibromyalgia,
More informationDrug Abuse Takes a Toll: Toll-Like Receptor 4 Signaling is Required for the Rewarding and Reinforcing Effects of Opioids, Cocaine, and Methamphetamine
University of Colorado, Boulder CU Scholar Psychology and Neuroscience Graduate Theses & Dissertations Psychology and Neuroscience Spring 1-1-2014 Drug Abuse Takes a Toll: Toll-Like Receptor 4 Signaling
More informationThe role of toll-like receptor 4 in pain due to glucuronidated metabolites and neuropathic pain
University of Colorado, Boulder CU Scholar Psychology and Neuroscience Graduate Theses & Dissertations Psychology and Neuroscience Spring 1-1-2011 The role of toll-like receptor 4 in pain due to glucuronidated
More informationOP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4
Opioid MCQ OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4 OP02 [Mar96] Which factor does NOT predispose to bradycardia with
More informationOST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO
OST Pharmacology & Therapeutics Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO Disclaimer In the past two years I have received no payment for services from any agency other than government or academic.
More informationDistribution Unlimited
AWARD NUMBER: W81XWH-12-1-0345 PROJECT TITLE: Combating drug abuse by targeting toll-like receptor 4 (TLR) PRINCIPAL INVESTIGATOR: Dr. Linda Watkins CONTRACTING ORGANIZATION: University of Colorado, Boulder
More informationSpinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats
1026 The Journal of Neuroscience, February 1, 2003 23(3):1026 1040 Spinal Glia and Proinflammatory Cytokines Mediate Mirror-Image Neuropathic Pain in Rats Erin D. Milligan, 1 Carin Twining, 1 Marucia Chacur,
More informationNIH Public Access Author Manuscript Eur J Neurosci. Author manuscript; available in PMC 2008 November 26.
NIH Public Access Author Manuscript Published in final edited form as: Eur J Neurosci. 2008 July ; 28(1): 20 29. doi:10.1111/j.1460-9568.2008.06321.x. Non-stereoselective reversal of neuropathic pain by
More information(1)-Naloxone, an Opioid-Inactive Toll-Like Receptor 4 Signaling Inhibitor, Reverses Multiple Models of Chronic Neuropathic Pain in Rats
The Journal of Pain, Vol 13, No 5 (May), 2012: pp 498-506 Available online at www.jpain.org and www.sciencedirect.com (1)-Naloxone, an Opioid-Inactive Toll-Like Receptor 4 Signaling Inhibitor, Reverses
More informationTITLE: Exploration of a Novel Persistent Reversal of Pathological Pain: Mechanisms and Mediators
AD Award Number: W81XWH-11-2-0070 TITLE: Exploration of a Novel Persistent Reversal of Pathological Pain: Mechanisms and Mediators PRINCIPAL INVESTIGATOR: Distinguished Professor Dr. Linda Watkins CONTRACTING
More informationMechanism of action of Low Dose Naltrexone (LDN)
Mechanism of action of Low Dose Naltrexone (LDN) Pradeep Chopra, MD Assistant Professor (Clinical) Brown Medical School, USA Director, Pain Management Center, RI, USA Copyright 2014 by Pradeep Chopra.
More informationMethadone Maintenance
Methadone Maintenance A Practical Guide to Pharmacotherapy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Ron Joe, MD, DABAM Objectives I. Pharmacology Of Methadone II. Practical Application of Pharmacology
More informationAnalgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer
Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I Mr.D.Raju,M.pharm, Lecturer Mechanisms of Pain and Nociception Nociception is the mechanism whereby noxious peripheral stimuli are transmitted to
More informationReview Polyanalgesic Consensus Charles Brooker Royal North Shore Hospital
Review Polyanalgesic Consensus 2007 Charles Brooker Royal North Shore Hospital cbrooker@med.usyd.edu.au Article review Polyanalgesic Consensus Conference 2007 Recommendations for the management of Pain
More information(+)-Morphine Activates Toll-like Receptor 4 (TLR4) in Endothelial Cells
University of Colorado, Boulder CU Scholar Undergraduate Honors Theses Honors Program Spring 2011 (+)-Morphine Activates Toll-like Receptor 4 (TLR4) in Endothelial Cells Anireddy Reddy University of Colorado
More informationTITLE: Exploration of a Novel Persistent Reversal of Pathological Pain: Mechanisms and Mediators
AD Award Number: W81XWH-11-2-0070 TITLE: Exploration of a Novel Persistent Reversal of Pathological Pain: Mechanisms and Mediators PRINCIPAL INVESTIGATOR: Dr. Linda Watkins CONTRACTING ORGANIZATION: REPORT
More informationUsing methadone alongside other opioids. Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS
Using methadone alongside other opioids Dr. Jo Murrell BVSc. (hons), PhD, DiplECVAA, MRCVS Why might we want to use methadone alongside other opioids? 1. Multi-modal analgesia strategies e.g. using methadone
More informationSpecial Issue on Pain and Itch
Special Issue on Pain and Itch Title: Recent Progress in Understanding the Mechanisms of Pain and Itch Guest Editor of the Special Issue: Ru-Rong Ji, PhD Chronic pain is a major health problem world-wide.
More informationSubstitution Therapy for Opioid Use Disorder The Role of Suboxone
Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM
More informationBuprenorphine pharmacology
Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely
More informationRapamycin suppresses astrocytic and microglial activation and reduces development of neuropathic pain after spinal cord injury in mice.
Rapamycin suppresses astrocytic and microglial activation and reduces development of neuropathic pain after spinal cord injury in mice. Satoshi Tateda, MD, Haruo Kanno, MD, PhD, Hiroshi Ozawa, MD, PhD,
More informationAcute Pain NETP: SEPTEMBER 2013 COHORT
Acute Pain NETP: SEPTEMBER 2013 COHORT Pain & Suffering an unpleasant sensory & emotional experience associated with actual or potential tissue damage, or described in terms of such damage International
More information6/6/2018. Nalbuphine: Analgesic with a Niche. Mellar P Davis MD FCCP FAAHPM. Summary of Advantages. Summary of Advantages
Nalbuphine: Analgesic with a Niche Mellar P Davis MD FCCP FAAHPM 1 Summary of Advantages Safe in renal failure- fecal excretion Analgesia equal to morphine with fewer side effects Reduced constipation
More informationExploring the Glial Mechanisms Underlying Central Neuropathic Pain in a Novel Rat Model of Spinal Cord Injury
University of Colorado, Boulder CU Scholar Psychology and Neuroscience Graduate Theses & Dissertations Psychology and Neuroscience Summer 6-23-2014 Exploring the Glial Mechanisms Underlying Central Neuropathic
More informationten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment
ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots
More informationSteven Prakken MD Director Medical Pain Service Duke Pain Medicine
Steven Prakken MD Director Medical Pain Service Duke Pain Medicine Misuse Abuse Addiction Total Pain Population Webster LR, Webster RM. Pain Med. 2005;6(6):432-442. DSM IV Abuse defined as 2 elements
More informationThe Effect of Morphine on Glial Cells as a Potential Therapeutic Target for Pharmacological Development of Analgesic Drugs
DOI 10.1007/s11916-010-0093-y The Effect of Morphine on Glial Cells as a Potential Therapeutic Target for Pharmacological Development of Analgesic Drugs Haroon Hameed & Mariam Hameed & Paul J. Christo
More information44th Annual CME Conference for Physician Assistants. Alexander Bautista, MD Assistant Professor Anesthesiology and Pain Medicine
44th Annual CME Conference for Physician Assistants Alexander Bautista, MD Assistant Professor Anesthesiology and Pain Medicine Fifth Vital Sign: 15 years later Opioid Epidemic Relevant Disclosure and
More informationThe Role of the Immune System in Translating Early-Life Experience to Later-Life Brain and Behavior
The Role of the Immune System in Translating Early-Life Experience to Later-Life Brain and Behavior STACI D. BILBO DEPARTMENT OF PSYCHOLOGY AND NEUROSCIENCE DUKE UNIVERSITY Thanks to! Dr. Mark Hutchinson
More informationRapamycin Suppresses Astrocytic and Microglial Activation and Reduced Development of Neuropathic Pain after Spinal Cord Injury in Mice.
Rapamycin Suppresses Astrocytic and Microglial Activation and Reduced Development of Neuropathic Pain after Spinal Cord Injury in Mice. Satoshi Tateda, M.D., Haruo Kanno, M.D., Ph.D., Hiroshi Ozawa, M.D.,
More informationCharles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus
Pain & Opioid Epidemic 2018 Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus Opioids 3400 BC Mesopotamia, Joy plant 1843 morphine by syringe 1874
More informationCU Scholar. University of Colorado, Boulder. Timothy Fabisiak Spring 2015
University of Colorado, Boulder CU Scholar Undergraduate Honors Theses Honors Program Spring 215 Expanding the Xenobiotic Hypothesis of Drug Reward and Reinforcement: Implications of TLR4 Dependent Cocaine
More informationCannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases Ana F. Paszcuk 1, Rafael C. Dutra 1, Kathryn A. B. S. da Silva 1, Nara
More informationPrescription Pain Management. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D
Prescription Pain Management University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita 1 Narciso Pharm D 2 Objectives Understand how to preform a pain assessment Know which medications
More informationBASIC VOLUME. Elements of Drug Dependence Treatment
BASIC VOLUME Elements of Drug Dependence Treatment Module 3 Principles of CBT and relapse prevention strategies Introduction to Cognitive Behavioural Therapy Basics of pharmacological treatment Workshop
More informationGlia as the bad guys : Implications for improving clinical pain control and the clinical utility of opioids
Brain, Behavior, and Immunity 21 (2007) 131 146 Norman Cousins Lecture www.elsevier.com/locate/ybrbi Glia as the bad guys : Implications for improving clinical pain control and the clinical utility of
More informationEffects of a Novel Fentanyl Derivative on Drug Discrimination and Learning in Rhesus Monkeys
PII S0091-3057(99)00058-1 Pharmacology Biochemistry and Behavior, Vol. 64, No. 2, pp. 367 371, 1999 1999 Elsevier Science Inc. Printed in the USA. All rights reserved 0091-3057/99/$ see front matter Effects
More informationProceedings of the World Small Animal Veterinary Association Sydney, Australia 2007
Proceedings of the World Small Animal Sydney, Australia 2007 Hosted by: Next WSAVA Congress REDUCING THE PAIN FACTOR AN UPDATE ON PERI-OPERATIVE ANALGESIA Sandra Forysth, BVSc DipACVA Institute of Veterinary,
More informationOpioid Pharmacology. Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd. Consultant Anaesthetist Sheffield Teaching Hospitals
Opioid Pharmacology Dr Ian Paterson, MA (Pharmacology), MB BS, FRCA, MAcadMEd Consultant Anaesthetist Sheffield Teaching Hospitals Introduction The available opioids and routes of administration - oral
More informationOpioids. Sergio Hernandez, MD
Opioids Sergio Hernandez, MD Required Slide Disclosures 1. SIGNIFICANT FINANCIAL INTERESTS NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT 2. GENERAL AND OBLIGATION INTERESTS All general
More informationLONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE
LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE DR. SHILPA ADARKAR ASSOCIATE PROFESSOR DEPARTMENT OF PSYCHIATRY & DRUG DEADDICTION CENTRE OF EXCELLENCE SETH GSMC & KEMH LONG TERM OPTIONS FULL AGONIST PARTIAL
More informationWhat it Takes to be a Pain
What it Takes to be a Pain Pain Pathways and the Neurophysiology of pain Dennis S. Pacl, MD, FACP, FAChPM Austin Palliative Care/ Hospice Austin A Definition of Pain complex constellation of unpleasant
More informationModule Two: Pharmacotherapies for Opioid Substitution Treatment
Module Two: Pharmacotherapies for Opioid Substitution Treatment Neurobiology of Addiction Pharmacology of Opioids Methadone Buprenorphine Pharmacokinetics of Methadone & Buprenorphine Opioid effects Intoxication
More informationXiaohui Wang, Report on ISN CAEN award Cat 1C return home Grant (Dec 2015)
Xiaohui Wang, Report on ISN CAEN award Cat 1C return home Grant (Dec 2015) Dr. Xiaohui Wang was a Post-Doc of University of Colorado-Boulder, USA. He moved back to Changchun Institute of Applied Chemistry,
More informationKaren F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine
Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine A 58 year old patient 20 year history of alcohol, opioid
More information3/15/2018. Pain. Pain. Opioid Analgesics Addiction. Pain
Pain Pain Well, I guess that explains the abdominal pains. Well, I guess that explains the abdominal pains. Pain is a component of virtually all clinical strategies, and management of pain is a primary
More informationPharmacotherapy for Substance Use Disorders
Pharmacotherapy for Substance Use Disorders Vanessa de la Cruz, MD Chief of Psychiatry Mental Health and Substance Abuse Services Santa Cruz County Health Services Agency 1400 Emeline Avenue Santa Cruz,
More informationChoose a category. You will be given the answer. You must give the correct question. Click to begin.
Instructions for using this template. Remember this is Jeopardy, so where I have written Answer this is the prompt the students will see, and where I have Question should be the student s response. To
More informationBehavioral implications of the dynamic regulation of microglia: the influence of a day versus a lifetime
Behavioral implications of the dynamic regulation of microglia: the influence of a day versus a lifetime Laura K. Fonken Postdoctoral Fellow University of Colorado March 20, 2017 About me: Research Timeline
More informationPrevention of Development of Tolerance and Dependence to Opiate in Mice by BR-16A (Mentat) A Herbal Psychotropic Preparation
[Indian Journal of Experimental Biology (1992): (30), 885] Prevention of Development of Tolerance and Dependence to Opiate in Mice by BR-16A (Mentat) A Herbal Psychotropic Preparation Kulkarni, S.K. and
More informationCXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5
The Journal of Clinical Investigation CXCL13 drives spinal astrocyte activation and neuropathic pain via CXCR5 Bao-Chun Jiang, 1 De-Li Cao, 1 Xin Zhang, 1 Zhi-Jun Zhang, 1,2 Li-Na He, 1 Chun-Hua Li, 1
More informationMorphine Following Peripheral Nerve Injury Potentiates the Magnitude and Duration of Subsequent Allodynia: A Role of Toll-like Receptor 4
University of Colorado, Boulder CU Scholar Undergraduate Honors Theses Honors Program Spring 2013 Morphine Following Peripheral Nerve Injury Potentiates the Magnitude and Duration of Subsequent Allodynia:
More informationOpioid Overdose Epidemic A Crises and Opportunity
Opioid Overdose Epidemic A Crises and Opportunity Samuel M. Silverman MD, FAPA, DFASAM Assistant Clinical Professor, UConn Medical School Director, Medical Education Rushford, A Hartford HealthCare Partner
More informationEmbargoed until Nov. 14, 2:30 p.m. EST Contacts: Kat Snodgrass, (202) Press Room, Nov : (202) Melissa Malski, (202)
Embargoed until Nov. 14, 2:30 p.m. EST Contacts: Kat Snodgrass, (202) 962-4090 Press Room, Nov. 12 16: (202) 249-4080 Melissa Malski, (202) 962-4051 STUDIES EXPLORE NEW APPROACHES TO TREATING PAIN Research
More informationNMDA-Receptor Antagonists and Opioid Receptor Interactions as Related to Analgesia and Tolerance
Vol. 19 No. 1(Suppl.) January 2000 Journal of Pain and Symptom Management S7 Proceedings Supplement NDMA-Receptor Antagonists: Evolving Role in Analgesia NMDA-Receptor Antagonists and Opioid Receptor Interactions
More informationNEUROBIOLOGY ALCOHOLISM
NEUROBIOLOGY ALCOHOLISM THERE HAS BEEN A MAJOR THEORETICAL SHIFT IN MEDICATION DEVELOPMENT IN ALCOHOLISM Driven by animal models of intermittent ethanol administration followed by termination, then access
More informationtablet/capsule Paracetamol 500mg
Formulary Item Restrictions and/or Advice Non-opioid analgesics + compound analgesic preparations Aspirin 75mg dispersible Aspirin 300mg dispersible Aspirin 300mg Aspirin 75mg EC Paracetamol 500mg / Paracetamol
More informationGOALS AND OBJECTIVES
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
More informationPREPARED FOR: U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland
AD Award Number: W81XWH-11-1-0637 TITLE: The role of glucocorticoids and neuroinflammation in mediating the effects of stress on drug abuse PRINCIPAL INVESTIGATOR: Steven F. Maier, Ph.D. CONTRACTING ORGANIZATION:
More information8/5/2013. MOSBIRT Annual Training The Big change in addiction medicine? Before we dive into pharmacotherapy
Medication Assisted Treatment for Substance Abuse in Primary Care Dan Vinson August 1, 2013 1 The Big change in addiction medicine? These diseases are rapidly becoming medical diseases. Done are the days
More informationPsychotropic Drugs in the Pipeline. Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine
Psychotropic Drugs in the Pipeline Norman Sussman, M.D. Professor of Psychiatry New York University School of Medicine Norman Sussman, MD No Conflict of Interest to Declare Antidepressant Pipeline We need
More informationDiscover the Hope: Opiate Treatment and Recovery
Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of
More informationOpioid Use in Youth. Amy Yule M.D. March 2,
Opioid Use in Youth Amy Yule M.D. March 2, 2018 An opioid is a substance that acts on opioid receptors Beta-endorphin Endogenous opioids Dynorphin Opiates Natural products of the poppy plant Morphine Heroin
More informationPain Management Strategies Webinar/Teleconference
Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits
More informationSafe Practices and Action Items
Safe Practices and Action Items Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine Case Study A 58 year
More informationMain Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders
Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?
More informationFrom opium to analgesic tests: An introduction to the functioning and studying of the opioid system
Practice-oriented, student-friendly modernization of the biomedical education for strengthening the international competitiveness of the rural Hungarian universities TÁMOP-4.1.1.C-13/1/KONV-2014-0001 From
More informationUltra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats
Psychopharmacology (2005) 181: 576 581 DOI 10.1007/s00213-005-0022-7 ORIGINAL INVESTIGATION Mary C. Olmstead. Lindsay H. Burns Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive
More informationOpioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description
More informationDrugs Used In Management Of Pain. Dr. Aliah Alshanwani
Drugs Used In Management Of Pain Dr. Aliah Alshanwani 1 Drugs Used In Management Of Pain A CASE OF OVERDOSE Sigmund Freud, the father of psychoanalysis His cancer of the jaw was causing him increasingly
More informationFrom opium to analgesic tests: An introduction to the functioning and studying of the opioid system
Practice-oriented, student-friendly modernization of the biomedical education for strengthening the international competitiveness of the rural Hungarian universities TÁMOP-4.1.1.C-13/1/KONV-2014-0001 From
More informationVIVITROL (naltrexone for extended-release injectable suspension) A µ-opioid Receptor Antagonist
MECHANISM OF ACTION VIVITROL (naltrexone for extended-release injectable suspension) A µ-opioid Receptor Antagonist VIVITROL is indicated for prevention of relapse to opioid dependence, following opioid
More informationLong term treatment for opioid dependence Antagonist therapy
Long term treatment for opioid dependence Antagonist therapy Treatment of Opioid Dependence Antagonist treatment Naltrexone Naltrexone (NTX) synthesized in 1965 Eliminate drug carving and prevent relapse
More informationAddiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017
Addiction Overview Causes Consequences Treatments Methadone/Buprenorphine 101 April 1, 2017 Diane A. Rothon MD Why? would you listen to this presentation Review the definition and neurobiology of addiction
More informationObjectives: What is your Definition of Pain? 8/16/2017
Safe Opioid Management for the Seriously Ill Patient Sam Perna, D.O. Objectives: MDB1 1) Participants will understand the way the body s pain system works. 2) Participants will identify the elements of
More informationSlide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists
Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics
More informationWhat is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls?
What is an opioid? What do opioids do? Why is there an opioid overdose crisis? What is fentanyl? What about illicit or bootleg fentanyls? What is an opioid? What do opioids do?: The term opioid can be
More informationOPIOIDS AND NON-CANCER PAIN
Ch05.qxd 1/6/04 4:33 PM Page 77 CHAPTER 5 OPIOIDS AND NON-CANCER PAIN Background 78 Side-effects of opioids 78 Tolerance, physical dependence and addiction 79 Opioid-induced pain 79 Practical issues 80
More informationLesson 33. Objectives: References: Chapter 16: Reading for Next Lesson: Chapter 16:
Lesson 33 Lesson Outline: Nervous System Structure and Function Neuronal Tissue Supporting Cells Neurons Nerves Functional Classification of Neuronal Tissue Organization of the Nervous System Peripheral
More informationBehavioral/Systems/Cognitive. Jaclyn M. Schwarz, 1 Mark R. Hutchinson, 2 and Staci D. Bilbo 1 1
The Journal of Neuroscience, December 7, 2011 31(49):17835 17847 17835 Behavioral/Systems/Cognitive Early-Life Experience Decreases Drug-Induced Reinstatement of Morphine CPP in Adulthood via Microglial-Specific
More informationResearch Article Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model
Neural Plasticity Volume 16, Article ID 523873, 12 pages http://dx.doi.org/.1155/16/523873 Research Article Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia
More informationDr. Hiwa K. Saaed. PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani Analgesic
12/17/18 Analgesics Opioids" Pharmacology Dr. Hiwa K. Saaed PhD Pharmacology & Toxicology College of Pharmacy, University of Sulaimani 2018-2019 1 Analgesic Analgesic an agent that selectively relieves
More informationCLINICAL POLICY DEPARTMENT: Medical
IMPTANT REMINDER This Clinical Policy has been developed by appropriately experienced and licensed health care professionals based on a thorough review and consideration of currently available generally
More informationTopics of today s training
Extended Release Naltrexone Vivitrol Christopher J Davis D.O. CAADC, FASAM Medical Director, Brightwater Landing Medical Director, Pyramid Healthcare Diplomate of The American Board of Addition Medicine
More informationSupplementary Figure 1. Microglia do not show signs of classical immune activation following MD a-b. Images showing immunoreactivity for MHCII (a)
1 Supplementary Figure 1. Microglia do not show signs of classical immune activation following MD a-b. Images showing immunoreactivity for MHCII (a) and CD45 (b) in fixed sections of binocular visual cortex
More informationNeurophysiology and Neurochemistry in PsychoGeriatrics
Tel Aviv University Sackler Faculty of Medicine CME in Psychiatry Neurophysiology and Neurochemistry in PsychoGeriatrics Nicola Maggio, MD, PhD Sackler Faculty of Medicine Tel Aviv University Department
More informationPrescription Opioids
What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made
More informationDisclosure. Objectives. Houston we have a problem! The epidemic of non medical use of prescription opioids. It all started with an observation
Houston we have a problem! The epidemic of non medical use of prescription opioids Myron Yaster, MD Professor, Department of Anesthesiology myron.yaster@childrenscolorado.org Disclosure I have participated/consutled
More informationSex Differences in the Efficacy of Combined IL-10 and IL-10R1 Gene Therapy for Neuropathic Pain in Mice
University of Colorado, Boulder CU Scholar Undergraduate Honors Theses Honors Program Spring 2016 Sex Differences in the Efficacy of Combined IL-10 and IL-10R1 Gene Therapy for Neuropathic Pain in Mice
More informationB-cell. Astrocyte SCI SCI. T-cell
RF #2015 P-01 PI: Azizul Haque, PhD Grant Title: Targeting Enolase in Spinal Cord Injury 12-month Technical Progress Report Progress Report (First Six Months): Enolase is one of the most abundantly expressed
More informationAgenda. Case Discussions. Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT. Daniel Alford, MD Disclosures
Managing Acute & Chronic Pain (requiring opioid analgesics) in Patients on MAT Case Discussions August 26, 2014 PCSS MAT Webinar Sponsored by the American Psychiatric Association Daniel P. Alford, MD,
More informationAnti-nerve growth factor antibody attenuates chronic morphine treatmentinduced tolerance in the rat
Cheppudira et al. BMC Anesthesiology (2016) 16:73 DOI 10.1186/s12871-016-0242-x RESEARCH ARTICLE Open Access Anti-nerve growth factor antibody attenuates chronic morphine treatmentinduced tolerance in
More informationComedy of Errors: Methadone and Buprenorphine
Comedy of Errors: Methadone and Buprenorphine Douglas Gourlay MD, MSc, FRCP(C), DFASAM Disclosures Nothing to disclosure 2 1 Learning Objectives Explain the pharmacology of methadone and buprenorphine
More informationOpioid-induced Central Immune Signaling: Implications for Opioid Analgesia
1 of 15 5/20/16 10:18 PM Abstract and Introduction www.medscape.com Opioid-induced Central Immune Signaling: Implications for Opioid Analgesia Peter M. Grace, PhD; Steven F. Maier, PhD; Linda R. Watkins,
More informationImplementing Buprenorphine Treatment in Opioid Treatment Programs Webinar 2, October 3, 2018
Implementing Buprenorphine Treatment in Opioid Treatment Programs Webinar 2, October 3, 2018 Judith Martin, MD, Medical Director of Substance Use Services, San Francisco Department of Public Health Webinar
More informationABSTRACT. Opioids are the most effective treatment for pain, but a host of side effects such as
ABSTRACT Opioids are the most effective treatment for pain, but a host of side effects such as lethal overdoses limits their use. Endomorphins are endogenous opioid ligands that show promise as a basis
More informationSUPPLEMENTARY INFORMATION
Supplementary Figure 1. Behavioural effects of ketamine in non-stressed and stressed mice. Naive C57BL/6 adult male mice (n=10/group) were given a single dose of saline vehicle or ketamine (3.0 mg/kg,
More information